Alzheimer's Disease Trial, By Invitation NCT07222449 Sponsor: China Medical University Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT07222449
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with either "Possible Alzheimer's Disease" or "Probable Alzheimer's Disease" according to the National Institute on Aging-Alzheimer's Association (NIA-AA) guidelines.
  • People who have sleep problems, shown by either a score above five on a standard sleep quality questionnaire (called the Pittsburgh Sleep Quality Index), or a score above four on a sleep-related section of a behaviour assessment completed by a caregiver (called the Neuropsychiatric Inventory).
  • People who are living in the community and attend psychiatric outpatient clinics, or take part in activities at dementia care centres or day care centres.
  • People for whom informed consent has been obtained before joining — if the person's memory or thinking difficulties make it hard for them to sign consent themselves, a primary caregiver (who may also be a legal or professional representative) may provide consent on their behalf.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with severe cataracts that significantly affect their sensitivity to light.
  • People with a physical condition (such as a wrist disability) that would prevent them from wearing a small wrist-worn movement monitor.
  • People who have had brain lesions or brain surgery that has permanently damaged the parts of the brain that control the body's daily rhythm (such as tumours affecting the suprachiasmatic nucleus or pineal gland).
  • People who have any other condition that the treating doctor considers unsuitable for participation, including people currently experiencing acute delirium or those suffering from a respiratory infection such as COVID-19.
  • For people taking part in Phase II of the trial specifically: people with significant skin conditions on the head, or conditions that could affect how well light therapy works — including haemangiomas, scleroderma, psoriasis, rashes, open wounds, or tattoos on the head — will not be eligible to participate, nor will people who have head implants or who have received photosensitising drug treatments within the two weeks before joining the trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
China Medical University Hospital
Registry
ClinicalTrials.gov
Start date
11 May 2026
Est. completion
30 September 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Sleep

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov